Synthesis, characterization and in silico studies of coumarin-chalcone derivatives and their cytotoxicity activity against breast cancer cells

被引:1
作者
Rahama, Muhammad Sulaiman [1 ,3 ]
Khairuddean, Melati [1 ]
Ismail, Noor Zafirah [1 ]
Al-Amin, Mohammad [2 ]
Salhimi, Salizawati Muhamad [2 ]
机构
[1] Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Penang, Malaysia
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Penang, Malaysia
[3] Umaru Musa Yaradua Univ, Dept Chem, Katsina, Nigeria
关键词
In silico study; Coumarin-chalcone; Cytotoxicity activity; Breast cancer cells; MOLECULAR DOCKING; BIOLOGICAL EVALUATION; DRUG DISCOVERY; ANTICANCER; PERFORMANCE; SOLUBILITY; INDUCTION; APOPTOSIS; DESIGN; LINES;
D O I
10.1016/j.molstruc.2024.140341
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Breast carcinoma disease is the most common ailment affecting women globally. Despite relentless efforts by scientists, numerous scientific strategies have been blocked by the aggressive nature of cancer cells, impeding their invasion, and spread to neighbouring tissues. This study aimed on evaluating the cytotoxic effects of newly synthesized coumarin chalcone compounds on breast cancer cell lines (MCF-7). The findings were compared with computational data derived from computer-assisted software and the Swiss ADME web tool. Molecular docking analyses indicated that all the synthesized compounds satisfied Lipinski's criteria. Furthermore, results from cytotoxicity assays demonstrated that compounds 5A, 5B, and 7A displayed significant efficacy against MCF-7 cells with IC50 (6.44 f 0.64 mu M, 8.48 f 1.06 mu M, 9.02 f 0.96 mu M), this finding indicated that the compounds highlighted above demonstrated greater cytotoxic effects against human breast cancer cells MCF-7 than the control drug Tamoxifen (IC50 = 17.42 f 1.48 mu M). Therefore, compounds 5A, 5B, and 7A could be considered promising compounds against MCF-7.
引用
收藏
页数:16
相关论文
共 62 条
[1]   Local anaesthetics and chemotherapeutic agents: a systematic review of preclinical evidence of interactions and cancer biology [J].
Abdelaatti, Ahmed ;
Buggy, Donal J. ;
Wall, Thomas P. .
BJA OPEN, 2024, 10
[2]   Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer [J].
Abotaleb, Mariam ;
Liskova, Alena ;
Kubatka, Peter ;
Busselberg, Dietrich .
BIOMOLECULES, 2020, 10 (02)
[3]   Synthesis and biological evaluation of some new coumarin derivatives [J].
Al-Haiza, MA ;
Mostafa, MS ;
El-Kady, MY .
MOLECULES, 2003, 8 (02) :275-286
[4]   Docking studies, synthesis, characterization, and cytotoxicity activity of new bis-chalcone derivatives [J].
Alidmat, Mohammad Murwih ;
Khairuddean, Melati ;
Salhimi, Salizawati Muhamad ;
Al-Amin, Mohammad .
BIOMEDICAL RESEARCH AND THERAPY, 2021, 8 (04) :4294-4306
[5]   An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities [J].
Annunziata, Francesca ;
Pinna, Cecilia ;
Dallavalle, Sabrina ;
Tamborini, Lucia ;
Pinto, Andrea .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) :1-83
[6]  
Bagastama Anjas Randy, 2020, Key Engineering Materials, V840, P270
[7]   An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective [J].
Bakchi, Bulti ;
Krishna, Ambati Dileep ;
Sreecharan, Ekambarapu ;
Ganesh, Veeramallu Bala Jaya ;
Niharika, Muraboina ;
Maharshi, Suryadevara ;
Puttagunta, Srinivasa Babu ;
Sigalapalli, Dilep Kumar ;
Bhandare, Richie R. ;
Shaik, Afzal B. .
JOURNAL OF MOLECULAR STRUCTURE, 2022, 1259
[8]   Recent advances and therapeutic journey of coumarins: current status and perspectives [J].
Barot, Kuldipsinh P. ;
Jain, Shailesh V. ;
Kremer, Laurent ;
Singh, Shubhra ;
Ghate, Manjunath D. .
MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (07) :2771-2798
[9]   BDDCS, the Rule of 5 and drugability [J].
Benet, Leslie Z. ;
Hosey, Chelsea M. ;
Ursu, Oleg ;
Oprea, Tudor I. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 101 :89-98
[10]   Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski's Rule of Five [J].
Chagas, Caroline Manto ;
Moss, Sara ;
Alisaraie, Laleh .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 549 (1-2) :133-149